Lv6
2100 积分 2022-12-09 加入
Prognostic impact of conversion surgery in patients with stage IV gastric cancer: A multicenter population-based cohort study
14小时前
已关闭
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
14小时前
待确认
Zolbetuximab: First Approval
14小时前
待确认
Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial
1天前
待确认
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
1天前
待确认
Multiple myeloma
1天前
待确认
Current Treatment Landscape and Advances in Lymphoma in China: A Special Issue
5天前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
19天前
已完结
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial
1个月前
已完结
Safety and Efficacy of Anlotinib-based Regimen in Patients with Unresectable or Metastatic Bone and Soft-tissue Sarcomas: A Retrospective Institutional Study
1个月前
已完结
皖公网安备34019202002308
